MY SIZE INC (MYSZ) Fundamental Analysis & Valuation

NASDAQ:MYSZ • US62844N4060

Current stock price

0.5775 USD
-0.03 (-5.31%)
At close:
0.564 USD
-0.01 (-2.34%)
After Hours:

This MYSZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MYSZ Profitability Analysis

1.1 Basic Checks

  • MYSZ had negative earnings in the past year.
  • MYSZ had a negative operating cash flow in the past year.
  • In the past 5 years MYSZ always reported negative net income.
  • In the past 5 years MYSZ always reported negative operating cash flow.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MYSZ's Return On Assets of -30.59% is on the low side compared to the rest of the industry. MYSZ is outperformed by 76.73% of its industry peers.
  • The Return On Equity of MYSZ (-48.86%) is worse than 69.09% of its industry peers.
Industry RankSector Rank
ROA -30.59%
ROE -48.86%
ROIC N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

  • MYSZ's Gross Margin of 38.67% is on the low side compared to the rest of the industry. MYSZ is outperformed by 77.45% of its industry peers.
  • In the last couple of years the Gross Margin of MYSZ has declined.
  • MYSZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MYSZ Health Analysis

2.1 Basic Checks

  • MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MYSZ has more shares outstanding
  • The number of shares outstanding for MYSZ has been increased compared to 5 years ago.
  • The debt/assets ratio for MYSZ has been reduced compared to a year ago.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -7.46, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -7.46, MYSZ is doing worse than 86.91% of the companies in the same industry.
  • MYSZ has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • MYSZ's Debt to Equity ratio of 0.13 is in line compared to the rest of the industry. MYSZ outperforms 50.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -7.46
ROIC/WACCN/A
WACC9.25%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 2.73 indicates that MYSZ has no problem at all paying its short term obligations.
  • MYSZ's Current ratio of 2.73 is fine compared to the rest of the industry. MYSZ outperforms 73.09% of its industry peers.
  • MYSZ has a Quick Ratio of 1.72. This is a normal value and indicates that MYSZ is financially healthy and should not expect problems in meeting its short term obligations.
  • MYSZ has a Quick ratio (1.72) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.72
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MYSZ Growth Analysis

3.1 Past

  • MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.91%, which is quite impressive.
  • MYSZ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.01%.
  • MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 165.15% yearly.
EPS 1Y (TTM)78.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.77%
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%39.86%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.40% on average over the next years. This is quite good.
  • MYSZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.22% yearly.
EPS Next Y37.13%
EPS Next 2Y15.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.74%
Revenue Next 2Y18.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

0

4. MYSZ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.
  • Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MYSZ's earnings are expected to grow with 15.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYSZ Dividend Analysis

5.1 Amount

  • MYSZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYSZ Fundamentals: All Metrics, Ratios and Statistics

MY SIZE INC

NASDAQ:MYSZ (3/31/2026, 6:37:12 PM)

After market: 0.564 -0.01 (-2.34%)

0.5775

-0.03 (-5.31%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27
Earnings (Next)N/A
Inst Owners3.45%
Inst Owner Change5.91%
Ins Owners14.96%
Ins Owner Change13.7%
Market Cap2.22M
Revenue(TTM)7.51M
Net Income(TTM)-3.56M
Analysts82.86
Price Target3.06 (429.87%)
Short Float %3.17%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-1.6
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS1.95
BVpS1.9
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.59%
ROE -48.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.67%
FCFM N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score3
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.72
Altman-Z -7.46
F-Score3
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)6.12%
Cap/Depr(5y)22.62%
Cap/Sales(3y)0.26%
Cap/Sales(5y)5.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.77%
EPS Next Y37.13%
EPS Next 2Y15.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%39.86%
Revenue Next Year2.74%
Revenue Next 2Y18.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.77%
OCF growth 3YN/A
OCF growth 5YN/A

MY SIZE INC / MYSZ Fundamental Analysis FAQ

What is the fundamental rating for MYSZ stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSZ.


What is the valuation status for MYSZ stock?

ChartMill assigns a valuation rating of 0 / 10 to MY SIZE INC (MYSZ). This can be considered as Overvalued.


What is the profitability of MYSZ stock?

MY SIZE INC (MYSZ) has a profitability rating of 0 / 10.


What is the expected EPS growth for MY SIZE INC (MYSZ) stock?

The Earnings per Share (EPS) of MY SIZE INC (MYSZ) is expected to grow by 37.13% in the next year.